Sat, Aug 30, 2014, 11:44 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • faosto faosto Dec 12, 2012 9:29 PM Flag

    Watch This

    To the end:

    http://www.huffingtonpost.com/2012/08/20/austin-and-max-leclaire-duchenne-muscular-dystrophy-eteplirsen_n_1812296.html

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • if the drug is so good, how come FDA is not approving it?? how come no big pharma has stepped up to partner with SRPT since Oct 3? If i am mistaken, let me know how. How come there is no buyout offer even when the price target is $160 and the stock is dirt cheap right now at mid $20s? Are you telling me big pharma is stupid & brainless to pass on a deal that good on a drug that works so wonderfully?

      If we can stand in line for hours and camp out for days to save a few bucks on Black Friday specials, how come no big pharma has bought out SRPT at dirt cheap price when they can possibly make gazillions in the future on a drug that works. Something does NOT add up here, and we all may not know what it is, and thats good enough reason for me to play it from the short side because it smells too darn fishy for me to go long with such obvious questions hanging around it, with longs having NO answer for it.
      and on top of that, you got dilution now. LOL

      Sentiment: Strong Sell

 
SRPT
22.93+0.80(+3.62%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Burger King Worldwide, Inc.
NYSEFri, Aug 29, 2014 4:02 PM EDT
Synaptics Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT